AR104212A1 - Formulaciones inyectables de liberación extendida que comprenden un agente activo de isoxazolina, métodos y usos de las mismas - Google Patents
Formulaciones inyectables de liberación extendida que comprenden un agente activo de isoxazolina, métodos y usos de las mismasInfo
- Publication number
- AR104212A1 AR104212A1 ARP160100953A ARP160100953A AR104212A1 AR 104212 A1 AR104212 A1 AR 104212A1 AR P160100953 A ARP160100953 A AR P160100953A AR P160100953 A ARP160100953 A AR P160100953A AR 104212 A1 AR104212 A1 AR 104212A1
- Authority
- AR
- Argentina
- Prior art keywords
- isoxazoline
- methods
- active agent
- liberation
- extended
- Prior art date
Links
- WEQPBCSPRXFQQS-UHFFFAOYSA-N 4,5-dihydro-1,2-oxazole Chemical compound C1CC=NO1 WEQPBCSPRXFQQS-UHFFFAOYSA-N 0.000 title abstract 2
- 239000013543 active substance Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000007972 injectable composition Substances 0.000 title 1
- 241001465754 Metazoa Species 0.000 abstract 3
- 238000013265 extended release Methods 0.000 abstract 2
- 238000009472 formulation Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 244000045947 parasite Species 0.000 abstract 2
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Formulaciones inyectables de liberación extendida para combatir parásitos en animales, que comprenden al menos un agente activo de isoxazolina, un polímero farmacéuticamente aceptable y un solvente. Métodos para erradicar, controlar y prevenir infecciones e infestaciones por parásitos en un animal que comprende administrar las formulaciones inyectables de liberación extendida de la presente a un animal que lo necesita.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562144871P | 2015-04-08 | 2015-04-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR104212A1 true AR104212A1 (es) | 2017-07-05 |
Family
ID=57072717
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP160100953A AR104212A1 (es) | 2015-04-08 | 2016-04-08 | Formulaciones inyectables de liberación extendida que comprenden un agente activo de isoxazolina, métodos y usos de las mismas |
Country Status (18)
Country | Link |
---|---|
US (2) | US20170020848A1 (es) |
EP (1) | EP3280413A1 (es) |
JP (2) | JP6824900B2 (es) |
KR (1) | KR102593069B1 (es) |
CN (1) | CN108055825B (es) |
AR (1) | AR104212A1 (es) |
AU (3) | AU2016246598B2 (es) |
BR (1) | BR112017021073A2 (es) |
CA (1) | CA2981797C (es) |
CL (1) | CL2017002536A1 (es) |
CO (1) | CO2017010065A2 (es) |
EA (2) | EA202090762A1 (es) |
IL (1) | IL254813B (es) |
MX (2) | MX2017012848A (es) |
NZ (1) | NZ736374A (es) |
SG (2) | SG10201912724SA (es) |
UY (1) | UY36610A (es) |
WO (1) | WO2016164487A1 (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UY37137A (es) * | 2016-02-24 | 2017-09-29 | Merial Inc | Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos |
WO2018039508A1 (en) | 2016-08-25 | 2018-03-01 | Merial, Inc. | Method for reducing unwanted effects in parasiticidal treatments |
JP7222909B2 (ja) * | 2017-04-05 | 2023-02-15 | ベーリンガー・インゲルハイム・アニマル・ヘルス・ユーエスエー・インコーポレイテッド | (s)-アフォキソラネルの結晶形 |
WO2018189314A1 (en) | 2017-04-13 | 2018-10-18 | Ceva Sante Animale | Composition for treating worms infestations |
BR112020008853A2 (pt) | 2017-11-07 | 2020-10-13 | Intervet International B.V. | composições farmacêuticas injetáveis de isoxazolina e seu uso contra infestação parasitária |
AU2018363686B2 (en) | 2017-11-07 | 2023-11-23 | Intervet International B.V. | Process for preparing large size isoxazoline particles |
BR112020011506A2 (pt) * | 2017-12-12 | 2020-11-17 | Intervet International B.V. | composições farmacêuticas de isoxazolina implantáveis e usos das mesmas |
TWI812673B (zh) * | 2018-02-12 | 2023-08-21 | 美商富曼西公司 | 用於防治無脊椎害蟲之萘異噁唑啉化合物 |
AR116524A1 (es) * | 2018-10-04 | 2021-05-19 | Elanco Tiergesundheit Ag | Potenciación de tratamiento de helmintos |
MX2021013429A (es) | 2019-05-03 | 2021-12-10 | Intervet Int Bv | Composiciones farmaceuticas inyectables y usos de las mismas. |
EP4153133B1 (en) * | 2020-05-20 | 2023-11-08 | Intervet International B.V. | Injectable pharmaceutical compositions and uses thereof |
IL309666A (en) | 2021-07-09 | 2024-02-01 | Plexium Inc | Aryl compounds and pharmaceutical preparations that modulate IKZF2 |
Family Cites Families (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3740421A (en) | 1966-09-19 | 1973-06-19 | Basf Wyandotte Corp | Polyoxyethylene-polyoxypropylene aqueous gels |
JPS4914624A (es) | 1972-06-08 | 1974-02-08 | ||
US3950360A (en) | 1972-06-08 | 1976-04-13 | Sankyo Company Limited | Antibiotic substances |
SE434277B (sv) | 1976-04-19 | 1984-07-16 | Merck & Co Inc | Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis |
US4134973A (en) | 1977-04-11 | 1979-01-16 | Merck & Co., Inc. | Carbohydrate derivatives of milbemycin and processes therefor |
US4199569A (en) | 1977-10-03 | 1980-04-22 | Merck & Co., Inc. | Selective hydrogenation products of C-076 compounds and derivatives thereof |
US4144352A (en) | 1977-12-19 | 1979-03-13 | Merck & Co., Inc. | Milbemycin compounds as anthelmintic agents |
US4203976A (en) | 1978-08-02 | 1980-05-20 | Merck & Co., Inc. | Sugar derivatives of C-076 compounds |
JPS57139012A (en) | 1981-02-23 | 1982-08-27 | Sankyo Co Ltd | Anthelmintic composition |
US4427663A (en) | 1982-03-16 | 1984-01-24 | Merck & Co., Inc. | 4"-Keto-and 4"-amino-4"-deoxy avermectin compounds and substituted amino derivatives thereof |
ATE67493T1 (de) | 1985-02-04 | 1991-10-15 | Bayer Agrochem Kk | Heterocyclische verbindungen. |
EP0237482A1 (de) | 1986-03-06 | 1987-09-16 | Ciba-Geigy Ag | C(29)-Carbonyloxi-milbemycin-Derivate zur Bekämpfung von tier- und pflanzenparasitären Schädlingen |
EP0246739B1 (en) | 1986-03-25 | 1991-01-23 | Sankyo Company Limited | Macrolide compounds, their preparation and their use |
ATE75745T1 (de) | 1986-07-02 | 1992-05-15 | Ciba Geigy Ag | Pestizide. |
US4855317A (en) | 1987-03-06 | 1989-08-08 | Ciba-Geigy Corporation | Insecticides and parasiticides |
US4871719A (en) | 1987-03-24 | 1989-10-03 | Ciba-Geigy Corporation | Composition for controlling parasites in productive livestock |
US4874749A (en) | 1987-07-31 | 1989-10-17 | Merck & Co., Inc. | 4"-Deoxy-4-N-methylamino avermectin Bla/Blb |
DE3888936T2 (de) | 1987-11-03 | 1994-07-21 | Beecham Group Plc | Zwischenprodukte für die Herstellung makrolider Antibiotika mit anthelmintischer Wirkung. |
NZ232422A (en) | 1989-02-16 | 1992-11-25 | Merck & Co Inc | 13-ketal milbemycin derivatives and parasiticides |
NZ247278A (en) | 1991-02-12 | 1995-03-28 | Ancare Distributors | Veterinary anthelmintic drench comprising a suspension of praziquantel in a liquid carrier |
US5330768A (en) | 1991-07-05 | 1994-07-19 | Massachusetts Institute Of Technology | Controlled drug delivery using polymer/pluronic blends |
US5345377A (en) | 1992-10-30 | 1994-09-06 | Electric Power Research Institute, Inc. | Harmonic controller for an active power line conditioner |
GB9300883D0 (en) | 1993-01-18 | 1993-03-10 | Pfizer Ltd | Antiparasitic agents |
AUPM969994A0 (en) | 1994-11-28 | 1994-12-22 | Virbac S.A. | Equine anthelmintic formulations |
US6207647B1 (en) | 1997-07-18 | 2001-03-27 | Smithkline Beecham Corporation | RatA |
US6733767B2 (en) * | 1998-03-19 | 2004-05-11 | Merck & Co., Inc. | Liquid polymeric compositions for controlled release of bioactive substances |
EA011764B1 (ru) | 2004-03-05 | 2009-06-30 | Ниссан Кемикал Индастриз, Лтд. | Изоксазолинзамещённое производное бензамида и пестицид |
US8362086B2 (en) | 2005-08-19 | 2013-01-29 | Merial Limited | Long acting injectable formulations |
AU2006285613B2 (en) | 2005-09-02 | 2011-11-17 | Nissan Chemical Corporation | Isoxazoline-substituted benzamide compound and harmful organism-controlling agent |
KR20080080168A (ko) | 2005-12-14 | 2008-09-02 | 이 아이 듀폰 디 네모아 앤드 캄파니 | 무척추 해충 방제용 이속사졸린 |
TW200803740A (en) | 2005-12-16 | 2008-01-16 | Du Pont | 5-aryl isoxazolines for controlling invertebrate pests |
TWI412322B (zh) | 2005-12-30 | 2013-10-21 | Du Pont | 控制無脊椎害蟲之異唑啉 |
KR20090005201A (ko) | 2006-04-20 | 2009-01-12 | 이 아이 듀폰 디 네모아 앤드 캄파니 | 무척추 해충 방제용 피라졸린 |
JP2008044880A (ja) | 2006-08-15 | 2008-02-28 | Bayer Cropscience Ag | 殺虫性イソオキサゾリン類 |
JP5256753B2 (ja) | 2007-03-29 | 2013-08-07 | 住友化学株式会社 | イソオキサゾリン化合物とその有害生物防除用途 |
RU2009141185A (ru) | 2007-04-10 | 2011-05-20 | Байер КропСайенс АГ (DE) | Инсектицидные производные арилизоксазолина |
EP2155701B1 (en) | 2007-06-13 | 2013-12-11 | E. I. Du Pont de Nemours and Company | Isoxazoline insecticides |
TWI430995B (zh) * | 2007-06-26 | 2014-03-21 | Du Pont | 萘異唑啉無脊椎有害動物控制劑 |
TWI556741B (zh) * | 2007-08-17 | 2016-11-11 | 英特威特國際股份有限公司 | 異唑啉組成物及其作為抗寄生蟲藥上的應用 |
CN101809004B (zh) | 2007-10-03 | 2012-12-26 | 杜邦公司 | 用于控制无脊椎害虫的萘异噁唑啉化合物 |
EP2306837B2 (en) | 2008-07-09 | 2023-10-25 | Basf Se | Pesticidal active mixtures comprising isoxazoline compounds i |
WO2010079077A1 (en) * | 2008-12-18 | 2010-07-15 | Novartis Ag | Isoxazolines derivatives and their use as pesticide |
ES2569486T3 (es) * | 2009-12-17 | 2016-05-11 | Merial, Inc. | Compuestos de dihidroazol antiparasitarios y composiciones que comprenden los mismos |
ES2566402T3 (es) * | 2010-05-27 | 2016-04-12 | E. I. Du Pont De Nemours And Company | Forma cristalina de 4-[5-[3-cloro-5-(trifluorometil)fenil]-4,5-dihidro-5-(trifluorometil)-3-isoxazolil]-N-[2-oxo-2-[(2,2,2-trifluoroetil)amino]etil]-1-naftalenocarboxamida |
DK178277B1 (da) * | 2010-06-18 | 2015-10-26 | Novartis Tiergesundheit Ag | Diaryloxazolinforbindelser til bekæmpelse af fiskelus |
WO2012089623A1 (en) | 2010-12-27 | 2012-07-05 | Intervet International B.V. | Topical localized isoxazoline formulation comprising glycofurol |
CA2826067A1 (en) * | 2011-02-10 | 2012-08-16 | Novartis Ag | Isoxazoline derivatives for controlling invertebrate pests |
RU2013145304A (ru) | 2011-03-10 | 2015-04-20 | Новартис Аг | Производные изоксазола |
ME02412B (me) | 2011-03-10 | 2016-09-20 | Zoetis Services Llc | Spirociklični derivati izoksazolina kao antiparazitska sredstva |
AU2012308776B2 (en) * | 2011-09-12 | 2016-04-14 | Boehringer Ingelheim Animal Health USA Inc. | Parasiticidal compositions comprising an isoxazoline active agent, methods and uses thereof |
AR088669A1 (es) * | 2011-11-21 | 2014-06-25 | Lilly Co Eli | Derivados de dihidrodibenzo[c][1,2]oxaborol y dihidroisoxazol utiles para el control de ectoparasitos |
AR088668A1 (es) * | 2011-11-21 | 2014-06-25 | Lilly Co Eli | Moleculas pequeñas que contienen boro |
ES2659159T3 (es) * | 2011-12-02 | 2018-03-14 | Merial, Inc. | Formulaciones de moxidectina inyectable de acción prolongada y nuevas formas cristalinas de moxidectina |
TR201902125T4 (tr) | 2012-02-06 | 2019-03-21 | Merial Inc | Si̇stemi̇k olarak etki̇ eden akti̇f ajanlari i̇çeren parazi̇ti̇si̇dal oral veteri̇nerli̇ğe ai̇t bi̇leşi̇mler, bunlarin yöntemleri̇ ve kullanimlari |
CA2882546A1 (en) | 2012-09-07 | 2014-03-13 | Zoetis Llc | Spirocyclic isoxazolines as antiparasitic agents |
SI2892347T1 (sl) | 2012-09-07 | 2019-10-30 | Zoetis Services Llc | Paraziticidne kombinacije spirocikličnega isoksazolina |
AR096346A1 (es) | 2013-05-20 | 2015-12-23 | Zoetis Llc | Composiciones antiparasitarias de espiro-isoxazolina de acción prolongada |
MX2016004035A (es) * | 2013-09-30 | 2016-06-02 | Zoetis Services Llc | Formulaciones de espiro-isoxazolina de accion prolongada. |
-
2016
- 2016-04-06 MX MX2017012848A patent/MX2017012848A/es unknown
- 2016-04-06 AU AU2016246598A patent/AU2016246598B2/en active Active
- 2016-04-06 SG SG10201912724SA patent/SG10201912724SA/en unknown
- 2016-04-06 EA EA202090762A patent/EA202090762A1/ru unknown
- 2016-04-06 CN CN201680031640.6A patent/CN108055825B/zh active Active
- 2016-04-06 EA EA201792235A patent/EA036272B1/ru not_active IP Right Cessation
- 2016-04-06 JP JP2017553068A patent/JP6824900B2/ja active Active
- 2016-04-06 SG SG11201708068PA patent/SG11201708068PA/en unknown
- 2016-04-06 EP EP16720949.3A patent/EP3280413A1/en active Pending
- 2016-04-06 US US15/092,491 patent/US20170020848A1/en not_active Abandoned
- 2016-04-06 NZ NZ736374A patent/NZ736374A/en unknown
- 2016-04-06 WO PCT/US2016/026253 patent/WO2016164487A1/en active Application Filing
- 2016-04-06 BR BR112017021073A patent/BR112017021073A2/pt not_active Application Discontinuation
- 2016-04-06 KR KR1020177032205A patent/KR102593069B1/ko active IP Right Grant
- 2016-04-06 CA CA2981797A patent/CA2981797C/en active Active
- 2016-04-08 AR ARP160100953A patent/AR104212A1/es active IP Right Grant
- 2016-04-08 UY UY0001036610A patent/UY36610A/es active IP Right Grant
-
2017
- 2017-10-01 IL IL254813A patent/IL254813B/en active IP Right Grant
- 2017-10-04 CO CONC2017/0010065A patent/CO2017010065A2/es unknown
- 2017-10-05 MX MX2022010831A patent/MX2022010831A/es unknown
- 2017-10-06 CL CL2017002536A patent/CL2017002536A1/es unknown
-
2020
- 2020-07-30 AU AU2020210266A patent/AU2020210266B2/en active Active
- 2020-11-20 JP JP2020193357A patent/JP2021050206A/ja active Pending
-
2021
- 2021-05-24 US US17/327,929 patent/US20210299104A1/en active Pending
-
2022
- 2022-03-24 AU AU2022202035A patent/AU2022202035A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
MX2022010831A (es) | 2022-09-29 |
IL254813B (en) | 2020-03-31 |
EA201792235A1 (ru) | 2018-01-31 |
AU2020210266B2 (en) | 2022-03-10 |
BR112017021073A2 (pt) | 2018-07-03 |
EA036272B1 (ru) | 2020-10-21 |
AU2022202035A1 (en) | 2022-04-14 |
KR20170134700A (ko) | 2017-12-06 |
CO2017010065A2 (es) | 2018-01-05 |
AU2016246598A1 (en) | 2017-11-02 |
EA202090762A1 (ru) | 2020-09-08 |
CA2981797C (en) | 2023-11-21 |
AU2020210266A1 (en) | 2020-08-20 |
CN108055825B (zh) | 2021-03-30 |
SG10201912724SA (en) | 2020-02-27 |
US20210299104A1 (en) | 2021-09-30 |
EP3280413A1 (en) | 2018-02-14 |
WO2016164487A1 (en) | 2016-10-13 |
US20170020848A1 (en) | 2017-01-26 |
NZ736374A (en) | 2024-02-23 |
IL254813A0 (en) | 2017-12-31 |
AU2016246598B2 (en) | 2020-07-23 |
JP6824900B2 (ja) | 2021-02-03 |
JP2021050206A (ja) | 2021-04-01 |
SG11201708068PA (en) | 2017-10-30 |
JP2018510897A (ja) | 2018-04-19 |
CA2981797A1 (en) | 2016-10-13 |
KR102593069B1 (ko) | 2023-10-23 |
UY36610A (es) | 2016-10-31 |
CN108055825A (zh) | 2018-05-18 |
CL2017002536A1 (es) | 2018-04-20 |
MX2017012848A (es) | 2018-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR104212A1 (es) | Formulaciones inyectables de liberación extendida que comprenden un agente activo de isoxazolina, métodos y usos de las mismas | |
NI201400842A (es) | Composiciones veterinarias orales parasiticidas que comprenden agentes activos de acción sistémica, métodos y usos de las mismas. | |
CL2017002164A1 (es) | Formulaciones inyectables de acción prolongada que comprenden un agente activo isoxazolina, métodos y usos de las mismas | |
CL2018002402A1 (es) | Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos | |
AR087838A1 (es) | Composiciones parasiticidas que comprenden un agente activo de isoxazolina, sus metodos y usos | |
CL2016002812A1 (es) | Uso de ácido 3-2,3,5,6-tetrafluoro-3-trifluorometoxi-bifenil-4-ilcarbamoil-tiofeno-2-carboxílico para preparar un medicamento útil para tratar una enfermedad ocular que es uveítis, ojo seco o causada por un adenovirus composición formulación. | |
CO2017006958A2 (es) | Formulaciones farmacéuticas que comprenden cangrelor de alta pureza y métodos para la preparación y uso de los mismos | |
CO7151497A2 (es) | Composiciones parasiticidas que comprenden derivados de benzimidazol, métodos y usos de los mismos | |
CL2017000178A1 (es) | Compuestos para usar en el tratamiento antihelmíntico | |
CL2016003271A1 (es) | Métodos para tratar infecciones | |
AR126245A2 (es) | Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos | |
CL2019001260A1 (es) | Formulaciones antimicrobianas para el tratamiento mejorado de infecciones veterinarias de pezuña | |
EA201300351A1 (ru) | Инъекционная ветеринарная композиция в виде раствора для борьбы с полиинвазиями животного и способ ее получения | |
TH147711A (th) | สารเร่งการแสดงออกของ trail |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration |